| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
VYNE Therapeutics (NASDAQ:VYNE) reported its Q3 earnings results on Monday, November 13, 2023 at 07:45 AM.
Here's what investors need to know about the announcement.
VYNE Therapeutics beat estimated earnings by 11.17%, reporting an EPS of $-1.75 versus an estimate of $-1.97.
Revenue was down $53 thousand from the same period last year.
Last quarter the company missed on EPS by $0.83 which was followed by a 19.3% drop in the share price the next day.
To track all earnings releases for VYNE Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: VYNE
